The Role of Critical N6-Methyladenosine-Related Long Non-Coding RNAs and Their Correlations with Immune Checkpoints in Renal Clear Cell Carcinoma

References

• Yang H, Xiong X, Li H. Development and interpretation of a genomic instability derived lncRNAs based risk signature as a predictor of prognosis for clear cell renal cell carcinoma patients. Front Oncol. 2021;11:678253. doi:10.3389/fonc.2021.678253
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. doi:10.3322/caac.21590
   PubMed Web of Science ®Google Scholar
• Ljungberg B, Albiges L, Abu-Ghanem Y, et al. European Association of Urology guidelines on renal cell carcinoma: the 2019 update. Eur Urol. 2019;75(5):799–810. doi:10.1016/j.eururo.2019.02.011
   PubMed Web of Science ®Google Scholar
• Hsieh JJ, Purdue MP, Signoretti S, et al. Renal cell carcinoma. Nat Rev. Dis Prim. 2017;3(1):17009. doi:10.1038/nrdp.2017.9
   PubMed Web of Science ®Google Scholar
• Wang X, Kong W, Wang Y, et al. Analysis of CT, MRI imaging features of renal cell carcinoma with different histopathological types. J BUON. 2021;26(5):2053–2058.
   PubMedGoogle Scholar
• Zeng Q, Zhang W, Li X, Lai J, Li Z. Bioinformatic identification of renal cell carcinoma microenvironment-associated biomarkers with therapeutic and prognostic value. Life Sci. 2020;243:117273. doi:10.1016/j.lfs.2020.117273
   PubMed Web of Science ®Google Scholar
• Hah YS, Koo KC. Immunology and immunotherapeutic approaches for advanced renal cell carcinoma: a comprehensive review. Int J Mol Sci. 2021;22(9):4452. doi:10.3390/ijms22094452
   PubMed Web of Science ®Google Scholar
• Díaz-Montero CM, Rini BI, Finke JH. The immunology of renal cell carcinoma. Nat Rev Nephrol. 2020;16(12):721–735. doi:10.1038/s41581-020-0316-3
   PubMed Web of Science ®Google Scholar
• Zambrana F, Carril-Ajuria L, Gómez de Liaño A, et al. Complete response and renal cell carcinoma in the immunotherapy era: the paradox of good news. Cancer Treat Rev. 2021;99:102239. doi:10.1016/j.ctrv.2021.102239
   PubMed Web of Science ®Google Scholar
• Zhao BS, Roundtree IA, He C. Post-transcriptional gene regulation by mRNA modifications. Nat Rev Mol Cell Biol. 2017;18(1):31–42. doi:10.1038/nrm.2016.132
   PubMed Web of Science ®Google Scholar
• Fustin JM, Doi M, Yamaguchi Y, et al. RNA-methylation-dependent RNA processing controls the speed of the circadian clock. Cell. 2013;155(4):793–806. doi:10.1016/j.cell.2013.10.026
   PubMed Web of Science ®Google Scholar
• Molinie B, Wang J, Lim KS, et al. m(6)A-LAIC-seq reveals the census and complexity of the m(6)A epitranscriptome. Nat Methods. 2016;13(8):692–698. doi:10.1038/nmeth.3898
   PubMed Web of Science ®Google Scholar
• Xu J, Liu Y, Liu J, et al. The identification of critical m(6)A RNA methylation regulators as malignant prognosis factors in prostate adenocarcinoma. Front Genet. 2020;11:602485. doi:10.3389/fgene.2020.602485
   PubMed Web of Science ®Google Scholar
• Chen M, Nie ZY, Wen XH, Gao YH, Cao H, Zhang SF. m6A RNA methylation regulators can contribute to malignant progression and impact the prognosis of bladder cancer. Biosci Rep. 2019;39(12):12. doi:10.1042/BSR20192892
   Web of Science ®Google Scholar
• Tu Z, Wu L, Wang P, et al. N6-methylandenosine-related lncRNAs are potential biomarkers for predicting the overall survival of lower-grade glioma patients. Front Cell Develop Biol. 2020;8:642. doi:10.3389/fcell.2020.00642
   PubMed Web of Science ®Google Scholar
• Ma S, Chen C, Ji X, et al. The interplay between m6A RNA methylation and noncoding RNA in cancer. J Hematol Oncol. 2019;12(1):121. doi:10.1186/s13045-019-0805-7
   PubMed Web of Science ®Google Scholar
• Chen XY, Zhang J, Zhu JS. The role of m(6)A RNA methylation in human cancer. Mol Cancer. 2019;18(1):103. doi:10.1186/s12943-019-1033-z
   PubMed Web of Science ®Google Scholar
• He L, Li H, Wu A, Peng Y, Shu G, Yin G. Functions of N6-methyladenosine and its role in cancer. Mol Cancer. 2019;18(1):176. doi:10.1186/s12943-019-1109-9
   PubMed Web of Science ®Google Scholar
• Sun T, Wu R, Ming L. The role of m6A RNA methylation in cancer. Biomed Pharmacother. 2019;112:108613. doi:10.1016/j.biopha.2019.108613
   PubMed Web of Science ®Google Scholar
• Zhang QJ, Luan JC, Song LB, et al. m6A RNA methylation regulators correlate with malignant progression and have potential predictive values in clear cell renal cell carcinoma. Exp Cell Res. 2020;392(1):112015. doi:10.1016/j.yexcr.2020.112015
   PubMed Web of Science ®Google Scholar
• Zhou J, Wang J, Hong B, et al. Gene signatures and prognostic values of m6A regulators in clear cell renal cell carcinoma - a retrospective study using TCGA database. Aging. 2019;11(6):1633–1647. doi:10.18632/aging.101856
   PubMedGoogle Scholar
• Gu Y, Niu S, Wang Y, et al. DMDRMR-mediated regulation of m(6) A-modified CDK4 by m(6)A reader IGF2BP3 drives ccRCC progression. Cancer Res. 2021;81(4):923–934. doi:10.1158/0008-5472.CAN-20-1619
   PubMed Web of Science ®Google Scholar
• Zhang C, Chen L, Liu Y, et al. Downregulated METTL14 accumulates BPTF that reinforces super-enhancers and distal lung metastasis via glycolytic reprogramming in renal cell carcinoma. Theranostics. 2021;11(8):3676–3693. doi:10.7150/thno.55424
   PubMed Web of Science ®Google Scholar
• Cao R, Yuan L, Ma B, Wang G, Tian Y. Immune-related long non-coding RNA signature identified prognosis and immunotherapeutic efficiency in bladder cancer (BLCA). Cancer Cell Int. 2020;20(1):276. doi:10.1186/s12935-020-01362-0
   PubMed Web of Science ®Google Scholar
• Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2016;17(1):47–62. doi:10.1038/nrg.2015.10
   PubMed Web of Science ®Google Scholar
• Chi Y, Wang J, Wang J, Yu W, Yang J. Long non-coding RNA in the pathogenesis of cancers. Cells. 2019;8(9):1015. doi:10.3390/cells8091015
   PubMed Web of Science ®Google Scholar
• Sanchez Calle A, Kawamura Y, Yamamoto Y, Takeshita F, Ochiya T. Emerging roles of long non-coding RNA in cancer. Cancer Sci. 2018;109(7):2093–2100. doi:10.1111/cas.13642
   PubMed Web of Science ®Google Scholar
• Wang W, Hu W, Wang Y, et al. Long non-coding RNA UCA1 promotes malignant phenotypes of renal cancer cells by modulating the miR-182-5p/DLL4 axis as a ceRNA. Mol Cancer. 2020;19(1):18. doi:10.1186/s12943-020-1132-x
   PubMed Web of Science ®Google Scholar
• Zaccara S, Ries RJ, Jaffrey SR. Reading, writing and erasing mRNA methylation. Nat Rev Mol Cell Biol. 2019;20(10):608–624. doi:10.1038/s41580-019-0168-5
   PubMed Web of Science ®Google Scholar
• Iasonos A, Schrag D, Raj GV, Panageas KS. How to build and interpret a nomogram for cancer prognosis. J Clin Oncol. 2008;26(8):1364–1370. doi:10.1200/JCO.2007.12.9791
   PubMed Web of Science ®Google Scholar
• Li R, Jiang S, Li W, et al. Exploration of prognosis-related microRNA and transcription factor co-regulatory networks across cancer types. RNA Biol. 2019;16(8):1010–1021. doi:10.1080/15476286.2019.1607714
   PubMed Web of Science ®Google Scholar
• Shang Z, Yu J, Sun L, et al. LncRNA PCAT1 activates AKT and NF-κB signaling in castration-resistant prostate cancer by regulating the PHLPP/FKBP51/IKKα complex. Nucleic Acids Res. 2019;47(8):4211–4225. doi:10.1093/nar/gkz108
   PubMed Web of Science ®Google Scholar
• Jiang H, Deng W, Zhu K, et al. LINC00467 promotes prostate cancer progression via M2 macrophage polarization and the miR-494-3p/STAT3 axis. Front Oncol. 2021;11:661431. doi:10.3389/fonc.2021.661431
   PubMed Web of Science ®Google Scholar
• You Z, Liu C, Wang C, et al. LncRNA CCAT1 promotes prostate cancer cell proliferation by interacting with DDX5 and MIR-28-5P. Mol Cancer Ther. 2019;18(12):2469–2479. doi:10.1158/1535-7163.MCT-19-0095
   PubMed Web of Science ®Google Scholar
• Luo H, Xu C, Le W, Ge B, Wang T. lncRNA CASC11 promotes cancer cell proliferation in bladder cancer through miRNA-150. J Cell Biochem. 2019;120(8):13487–13493. doi:10.1002/jcb.28622
   PubMed Web of Science ®Google Scholar
• Cao HL, Liu ZJ, Huang PL, Yue YL, Xi JN. lncRNA-RMRP promotes proliferation, migration and invasion of bladder cancer via miR-206. J Cell Biochem. 2019;23(3):1012–1021.
   Google Scholar
• Wang A, Bao Y, Wu Z, et al. Long noncoding RNA EGFR-AS1 promotes cell growth and metastasis via affecting HuR mediated mRNA stability of EGFR in renal cancer. Cell Death Dis. 2019;10(3):154. doi:10.1038/s41419-019-1331-9
   PubMed Web of Science ®Google Scholar
• Ni W, Yao S, Zhou Y, et al. Long noncoding RNA GAS5 inhibits progression of colorectal cancer by interacting with and triggering YAP phosphorylation and degradation and is negatively regulated by the m(6)A reader YTHDF3. Mol Cancer. 2019;18(1):143. doi:10.1186/s12943-019-1079-y
   PubMed Web of Science ®Google Scholar
• Lan T, Li H, Zhang D, et al. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3. Mol Cancer. 2019;18(1):186. doi:10.1186/s12943-019-1106-z
   PubMed Web of Science ®Google Scholar
• Osipov A, Saung MT, Zheng L, Murphy AG. Small molecule immunomodulation: the tumor microenvironment and overcoming immune escape. J Immunother Cancer. 2019;7(1):224. doi:10.1186/s40425-019-0667-0
   PubMed Web of Science ®Google Scholar
• Safarzadeh E, Asadzadeh Z, Safaei S, et al. MicroRNAs and lncRNAs-A new layer of myeloid-derived suppressor cells regulation. Front Immunol. 2020;11:572323. doi:10.3389/fimmu.2020.572323
   PubMed Web of Science ®Google Scholar
• Sun Z, Jing C, Xiao C, Li T. Long non-coding RNA Profile Study identifies an immune-related lncRNA prognostic signature for kidney renal clear cell carcinoma. Front Oncol. 2020;10:1430. doi:10.3389/fonc.2020.01430
   PubMed Web of Science ®Google Scholar
• Zhang Z, Tang Y, Liu Y, et al. A novel immune-related lncRNA-based model for survival prediction in clear cell renal cell carcinoma. Journal of Immunol Res. 2021;2021:9921466. doi:10.1155/2021/9921466
   PubMed Web of Science ®Google Scholar
• Liu J, Mei J, Wang Y, et al. Development of a novel immune-related lncRNA signature as a prognostic classifier for endometrial carcinoma. Int J Biol Sci. 2021;17(2):448–459. doi:10.7150/ijbs.51207
   PubMed Web of Science ®Google Scholar
• Zhang Y, Zhang L, Xu Y, Wu X, Zhou Y, Mo J. Immune-related long noncoding RNA signature for predicting survival and immune checkpoint blockade in hepatocellular carcinoma. J Cell Physiol. 2020;235(12):9304–9316. doi:10.1002/jcp.29730
   PubMed Web of Science ®Google Scholar
• Pan Q, Wang L, Chai S, Zhang H, Li B. The immune infiltration in clear cell renal cell carcinoma and their clinical implications: a study based on TCGA and GEO databases. J Cancer. 2020;11(11):3207–3215. doi:10.7150/jca.37285
   PubMed Web of Science ®Google Scholar
• Chen QF, Kong JL, Zou SC, et al. LncRNA LINC00342 regulated cell growth and metastasis in non-small cell lung cancer via targeting miR-203a-3p. J Cell Biochem. 2019;23(17):7408–7418.
   Google Scholar
• Tang H, Zhao L, Li M, Li T, Hao Y. Investigation of LINC00342 as a poor prognostic biomarker for human patients with non-small cell lung cancer. J Cell Biochem. 2019;120(4):5055–5061. doi:10.1002/jcb.27782
   PubMed Web of Science ®Google Scholar
• Miao Z, Liu S, Xiao X, Li D. LINC00342 regulates cell proliferation, apoptosis, migration and invasion in colon adenocarcinoma via miR-545-5p/MDM2 axis. Gene. 2020;743:144604. doi:10.1016/j.gene.2020.144604
   PubMed Web of Science ®Google Scholar
• Shen P, Qu L, Wang J, et al. LncRNA LINC00342 contributes to the growth and metastasis of colorectal cancer via targeting miR-19a-3p/NPEPL1 axis. Cancer Cell Int. 2021;21(1):105. doi:10.1186/s12935-020-01705-x
   PubMed Web of Science ®Google Scholar
• Wang J, Zhang C, He W, Gou X. Construction and comprehensive analysis of dysregulated long non-coding RNA-associated competing endogenous RNA network in clear cell renal cell carcinoma. J Cell Biochem. 2018;120(2):2576–293.
   PubMed Web of Science ®Google Scholar
• Hennessy EJ, van Solingen C, Scacalossi KR, et al. The long noncoding RNA CHROME regulates cholesterol homeostasis in primate. Nat Metab. 2019;1(1):98–110. doi:10.1038/s42255-018-0004-9
   PubMedGoogle Scholar
• Le Bras A. The lncRNA CHROME regulates cholesterol homeostasis. Nat Rev Cardiol. 2019;16(2):71. doi:10.1038/s41569-018-0154-1
   PubMed Web of Science ®Google Scholar
• Luo J, Yang H, Song BL. Mechanisms and regulation of cholesterol homeostasis. Nat Rev Mol Cell Biol. 2020;21(4):225–245. doi:10.1038/s41580-019-0190-7
   PubMed Web of Science ®Google Scholar